A new wave of wholesale and retail medical restructuring is coming。
On 1 july, the regulations on the management of the storage and transport of drug wholesale enterprises of the guangdong department of drug supervision began to be implemented, and support for the integrated wholesale and retail operations of drug wholesale and retail chains was recognized as an important initiative for the innovative drug business model in guangdong. In a recent study conducted by the ecd unit in the host institution, it has also been stated that the company retail block plans to develop 1,000 retail pharmacies in 2023 and to promote the rapid expansion of retail pharmacies by commercial enterprises throughout the country, with a view to achieving zero integration。
Wholesale zeros can open pharmacies, increase market ownership, or end-to-end pharmacies open their own wholesale channels. In the new situation, the batch of zeros would grow at a much larger, higher scale and faster pace。
Fully qualified
The series of zero-sum reforms, which began in the 1980s as a pilot project for the reform of the grass-roots medical transport sector in our country, is a re-creation of value based on the integration of industrial chains. In 2010, the national programme for the development of the drug-circulation sector (2011-2015) for the first time offered an incentive for zero integration. To date, the pharmaceutical market has changed dramatically, but batch zero remains an alternative direction, perhaps more so. In particular:
1. Greater market dynamism of multiple market players
The pharmaceutical business, and in particular the market for its wholesale distribution, is no longer the norm for third-tier wholesalers. There are more private-sector, joint-stock enterprises with autonomy and each making business decisions appropriate for its own development。
2. The size of pharmaceutical commercial enterprises is larger
Previously, although the geographical coverage of the third-tier wholesale companies had been relatively broad, covering the administrative regions of the provinces, municipalities and counties, the facilities were poor, the services were incomplete, the variety of businesses was small and the scale of operations was small. Today, large-scale enterprises are emerging, creating the conditions for a single batch。
On 12 july, fortune published a list of top 500 chinese companies listed in 2023 and 17 pharmaceutical companies. In the list of “medicine, biological products, health-care industries”, medicines are controlled by the four largest countries, and are controlled by the four largest countries. The highest ranking is the national drug control stock, which ranks china at 500 and 24 at 55,215 million yuan, followed by the shanghai medicines, chinese medicines group and kyushu, with the top 100。
3. Greater emphasis by enterprises on industrial chains
In the past, the field of medical circulation has not only been multi-competent, but has been characterized by a single model, operating in the same way, competing in the same quality, and in some cases generating internal consumption. The outward expansion of wholesale to retail and retail to wholesale is an innovative path. In addition, enterprises can create their own market brands through a zero-sum system that greatly enhances the social credibility and market image of pharmaceutical enterprises。
4. Accelerated zero integration of electronic commerce
The development of the internet has not only accelerated the integration of wholesale and retail sales, but also created a third-party platform for more drug-related subjects to provide drug network services。
Different transition characteristics
Over the past two years, the policies related to the integrated management of medicines in guangdong, chongqing, shandong and jiangxi have been issued as an excellent development opportunity for pharmaceutical enterprises。
According to the authors, the majority of zero enterprises have three characteristics: first, they are better run, they have a good market image and a law-abiding record, they have a strong economic power, which may be zero, zero and zero; secondly, they are larger in size, business (sale) channels, talent and social influence; and thirdly, they have ambitious decision-makers with ideas and ideas for change and development, large-scale impulses and strengths, and are willing to make a new struggle for enterprise growth。
From wholesale to retail
Wholesale enterprises have access to the pharmaceutical marketing channels of the producing enterprises and have expertise in the business. Currently, single-body pharmacies account for about 40 per cent of the total number of medical retail enterprises; there are few large-scale inter-provincial and inter-municipal establishments in the pharmaceutical retail chain. It is not impossible for a powerful wholesale pharmaceutical enterprise to establish retail chains based on its city, starting at a higher level and thus covering the province, the radiation region and the whole country。
The distribution of medicines by pharmaceutical wholesalers has been significantly reduced, especially since policies such as aggregating have been implemented, and pharmaceutical wholesalers have had to find alternatives。
2. Wholesale from retail
Economically powerful retail chains of medicines, which are larger (number of pharmacies, coverage of cities, sales volume, sales volume, market reputation), are well placed to extend upstream of the industrial chain. A chain of firms could first establish marketing companies to distribute pharmaceutical products to their own stores, then increase the variety, scale up and create a platform for the distribution of goods needed by society's medical retail enterprises。
Inadequate, small-scale and geographically limited single-body pharmacies and small pharmaceutical chains can also be used as retail outlets by wholesale and wholesale pharmaceutical enterprises. This has helped to raise the profile and strength of the various businesses and services involved in future reforms, such as the approval of a family doctor system and the establishment of community health centres。
3. Size
Small and large enterprises can be encouraged to complement each other through capital or business alliances if they do not have the capacity to do so. For example, small wholesalers become marketing companies in association with large, willing retail chains; small retail chains or single-body pharmacies can join with large wholesalers as retail chains or door shops subordinate to them. This will lead to a major shuffle in the market for medicine。
In either case, the bulk of the new enterprise could reduce the cost of doing business by combining wholesale and retail resources within the enterprise, reducing duplication, increasing the number of operations and integrating the same management. In such a dramatic shift in the market for medicines, it is believed that the relevant sectors will be optimistic。
This is an original media platform for the medical economy. They may not be used in any way, including reproduction, abstraction, reproduction or mirroring, without authorization from the medical economics newspaper. In order to obtain an authorization, contact me proactively: 020-37886610 or 020-37886753; yyjjb@21cn. Com。
